Espenhain, Laura http://orcid.org/0000-0003-0805-5199
Jørgensen, Silje Bakken
Leegaard, Truls Michael
Lelek, Michaela Marie
Hänsgen, Siri Haug
Nakstad, Britt
Sunde, Marianne
Steinbakk, Martin
Article History
Received: 23 August 2018
Accepted: 30 October 2018
First Online: 29 November 2018
Ethics approval and consent to participate
: The Regional Committees for Medical and Health Research Ethics (REC 2012/2234) and the privacy protection officer at Akershus University hospital approved the study protocol. Informed consent was obtained from each patient or parents of patients below 16 years of age.
: Not applicable
: The authors LE, SBJ, TML, MSu, SHH and MSt declare that they have no competing interests. BN has received funding from MSD as national lead invesgitator in Phamacokinetics Phase 1 study MK 1986 (Tedizolid) and 7655 (combination of imipenem, cilastatin and relebactam) for children outside of the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.